Radiofrequency ablation of breast tumors along with the intralesional administration of IL-7 and IL-15 induce anti-tumor immune responses and inhibit tumor relapse and metastasis

被引：0
|
作者：
Habibi, M. [1 ]
Manjili, M. [2 ]
Bear, H. D. [2 ]
Keeler, J. M. [2 ]
Kmieciak, M. [2 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 27 条
  • [21] NKTR-255, a polymer-conjugated IL-15 enhances anti-tumor NK cell responses and synergizes with monoclonal antibodies to provide long-term survival in human lymphoma model
    Miyazaki, Takahiro
    Kivimae, Saul
    Pena, Rhoneil
    Kuo, Peiwen
    Hennessy, Marlene
    Addepalli, Murali
    Dixit, Neha
    Nieves, Wildaliz
    Sheibani, Sara
    Maiti, Mekhala
    VanderVeen, Laurie
    Wilczek, Joanna
    Madakamutil, Loui
    Zalevsky, Jonathan
    CANCER RESEARCH, 2019, 79 (13)
  • [22] IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
    Kim, Peter S.
    Kwilas, Anna R.
    Xu, Wenxin
    Alter, Sarah
    Jeng, Emily K.
    Wong, Hing C.
    Schlom, Jeffrey
    Hodge, James W.
    ONCOTARGET, 2016, 7 (13) : 16130 - 16145
  • [23] IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+T cells, and mediates potent anti-tumor activity of murine breast and colon carcinomas
    Kim, Peter S.
    Kwilas, Anna R.
    Xu, Wenxin
    Alter, Sarah
    Jeng, Emily K.
    Wong, Hing C.
    Schlom, Jeffrey
    Hodge, James W.
    CANCER RESEARCH, 2016, 76
  • [24] Single-Dose Anti-PD-L1/IL-15 Fusion Protein KD033 Generates Synergistic Antitumor Immunity with Robust Tumor-Immune Gene Signatures and Memory Responses
    Martomo, Stella A.
    Lu, Dan
    Polonskaya, Zhanna
    Luna, Xenia
    Zhang, Zhikai
    Feldstein, Sam
    Lumban-Tobing, Radovan
    Almstead, Danielle K.
    Miyara, Faical
    Patel, Jeegar
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (02) : 347 - 356
  • [25] SO-C101, A HIGH-AFFINITY IL-15RBG AGONIST, INDUCES SAFE AND POTENT ANTI-TUMOR IMMUNE ACTIVITIES IN PATIENTS WITH SOLID TUMORS AND SUPPORTS FURTHER CLINICAL INVESTIGATIONS
    Palova, Lenka
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A541 - A541
  • [26] Rapid Personalized Manufacture (RPM) of Sleeping Beauty System-Generated NY-ESO-1-Specific TCR-T Cells Co-Expressing Membrane-Bound IL-15 Yields Anti-Tumor Responses
    Hurton, Lenka V.
    Mi, Tiejuan
    Switzer, Kirsten C.
    Zhang, Ling
    Dai, Cuiping
    Kim, Misun
    Bavisi, Karishma R.
    Figliola, Matthew J.
    Lydia, Vazquez M.
    Maiti, Sourindra N.
    Su, Shihuang
    Deniger, Drew C.
    Olivares, Simon
    Cooper, Laurence J. N.
    Singh, Harjeet
    BLOOD, 2019, 134
  • [27] Improved anti-tumor immune functions of iPSC-derived NK cells with TGFβR2 knock-out and/or IL-15 knock-in by TALEN® editing for use alone or in combination with GPC3 Flex-NK™ bispecific antibody
    Lin, Liang
    Gao, Peng
    Chen, An-Ping
    Chang, Hao-Ming
    Ashok, Preeti
    Zou, David
    Ma, Marshall Chao
    Eyquem, Justin
    Boyne, Alex
    Juillerat, Alexandre
    Poirot, Laurent
    Duchateau, Philippe
    Rath, Armin
    Burchi, Elisabetta
    Teper, Daniel
    Arulanandam, Antonio
    Li, Wei
    CANCER RESEARCH, 2023, 83 (07)
123